US Patent Issued to ACADEMIA SINICA on Jan. 20 for "Ligands targeted to epidermal growth factor receptors and compositions for use in treating tumors" (Taiwanese Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,879, issued on Jan. 20, was assigned to ACADEMIA SINICA (Taipei, Taiwan).

"Ligands targeted to epidermal growth factor receptors and compositions for use in treating tumors" was invented by Han-Chung Wu (Taipei, Taiwan), Yi-Ping Wang (Taipei, Taiwan), I-Ju Liu (Taipei, Taiwan) and Meng-Jhe Chung (New Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to ligands targeted to epidermal growth factor receptor (EGFR) and compositions for use in treating tumors. Specifically, a ligand targeted to EGFR is disclosed. The ligand comprises a heavy chain variable domain and a light chain variable domain. The ligand ma...